Oncology PracticeDiscontinuing immunotherapy: Is the infusion bag half empty or half full?November 23, 2022Lung CancerCNS/Brain CancerGastrointestinal CancerGenitourinary CancerGynecologic CancerHead & Neck/Thyroid CancersImmuno-oncology
Oncology PracticeHow AI is, or will soon be, relevant in radiation oncologyNovember 13, 2022Lung CancerBreast CancerGastrointestinal CancerGenitourinary CancerGynecologic CancerHead & Neck/Thyroid CancersMetastatic Breast Cancer
Oncology PracticeChronic stress, especially race related, may hasten cancer deathNovember 13, 2022Diversity in MedicineGastrointestinal CancerGenitourinary CancerGynecologic CancerHead & Neck/Thyroid CancersLung CancerMelanoma
Oncology PracticeThird COVID booster benefits cancer patientsNovember 12, 2022COVID-19 UpdatesBreast CancerGastrointestinal CancerGynecologic CancerGenitourinary CancerHead & Neck/Thyroid CancersLung Cancer
Oncology PracticeFindings may be practice changing for early breast cancer patientsOctober 31, 2022Metastatic Breast CancerBreast Cancer
Oncology PracticeStudy affirms better breast cancer outcomes when chemo comes firstOctober 26, 2022Metastatic Breast CancerBreast Cancer
Oncology PracticeCancer as a full contact sportOctober 3, 2022Patient & Survivor CarePractice ManagementRenal Cell CarcinomaMetastatic Breast CancerMixed TopicsMelanomaLung Cancer
Oncology PracticeCost paramount when choosing metastatic breast cancer treatmentSeptember 30, 2022Metastatic Breast CancerBreast Cancer
Oncology PracticeFDA OKs selpercatinib for adults with RET-fusion+ solid tumorsSeptember 23, 2022Lung CancerHead & Neck/Thyroid CancersGastrointestinal CancerMetastatic Breast Cancer
Oncology PracticeHigh BMI linked to better survival for cancer patients treated with ICI, but for men onlySeptember 22, 2022Lung CancerBreast CancerGastrointestinal CancerGynecologic CancerGenitourinary CancerHead & Neck/Thyroid CancersMetastatic Breast Cancer
Oncology PracticeA farewell to arms? Drug approvals based on single-arm trials can be flawedSeptember 19, 2022Gastrointestinal CancerPractice ManagementMixed TopicsBreast CancerCNS/Brain CancerGenitourinary CancerGynecologic Cancer
Oncology PracticeTime to cancer diagnoses in U.S. averages 5 monthsSeptember 15, 2022Breast CancerCNS/Brain CancerGastrointestinal CancerGenitourinary CancerGynecologic CancerHead & Neck/Thyroid CancersLung Cancer
Oncology PracticeTumor-bed radiotherapy boost reduces DCIS recurrence riskAugust 29, 2022Metastatic Breast CancerBreast Cancer
Oncology PracticeGetting cancer research on track again may require a ‘behemoth’ effortAugust 15, 2022Mixed TopicsBusiness of MedicineBreast CancerCNS/Brain CancerGastrointestinal CancerGenitourinary CancerGynecologic Cancer
Oncology PracticeFDA approves trastuzumab-deruxtecan for HER2-low breast cancerAugust 5, 2022Metastatic Breast CancerBreast Cancer
